SCHEMBL15075611

SCHEMBL15075611

COc1ccc(-c2nc(-c3ccncc3)[nH]c2-c2ccc(OC)cc2)cc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 9/20 0.89
MAPK12 P53778 9/20 0.89
MAPK11 Q15759 9/20 0.89
MAPK14 Q16539 9/20 0.89
RAF1 P04049 4/20 0.89
GCGR P47871 5/20 0.87
ALOX5 P09917 2/20 0.87
NOX1 Q9Y5S8 1/20 0.74
TGFBR1 P36897 1/20 0.68
MAPT P10636 3/20 0.67
TP53 P04637 2/20 0.67
MAPK9 P45984 2/20 0.66
PRKD3 O94806 1/20 0.66
MAP4K4 O95819 1/20 0.66
FRK P42685 1/20 0.66
CSNK1A1 P48729 1/20 0.66
CSNK1D P48730 1/20 0.66
GSK3B P49841 1/20 0.66
PTK6 Q13882 1/20 0.66
PRKD2 Q9BZL6 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6469341 0.94 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL6469323 0.93 MAPK13 (0.79) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL6164173 0.93 MAPK13 (0.79) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL2648503 0.93 MAPK11 (1.00) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL8008805 0.92 NOX1 (0.85) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL15400824 0.92 NOX1 (0.85) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL8388860 0.92 MAPK13 (0.77) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL3455232 0.87 NOX1 (0.77) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL8104080 0.86 MAPK13 (0.86) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL1308320 0.86 MAPK13 (0.86) MAPK13MAPK12MAPK11MAPK14RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165472-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165472-A1 HETEROARYLS AND USES THEREOF PIK3R4, VPS4B, PIK3C2A MAPK13 1623/4885MAPK12 2139/4885MAPK11 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.